首页 | 本学科首页   官方微博 | 高级检索  
     

填精补血化瘀口服液对实验性动脉硬化鹌鹑纤溶活性的影响及机理研究
引用本文:张冰, 卢咏才. 填精补血化瘀口服液对实验性动脉硬化鹌鹑纤溶活性的影响及机理研究[J]. 中国现代应用药学, 1996, (6): 17-19.
作者姓名:张冰  卢咏才
作者单位:北京中医药大学中药学院
摘    要:填精补血化瘀口服液具有升高食饵性动脉硬化(Atherosclerosis,AS)鹌鹑血浆组织型纤溶酶元激活物(TissuePlasminogenactivitor,t-PA)活性,降低纤溶酶元激活物抑制物(Plasminogenactivitorinhibitor,PAI)活性;调整二者活性比,恢复纤溶系统功能。其作用机理可能与该方药减少动脉壁脂质沉积,改善血液流变性,减轻动脉内膜损伤,保护平滑肌细胞及内皮细胞功能活动有关.因而,该方药对治疗AS,尤其是防止AS的恶化,都具有积极意义。

关 键 词:组织型纤溶酶元激活物  抑制物活性  动脉硬化  病理学  血液流变学

Study on the Effect and Mechanism of Tianjing Buxue Huayu OralLiquid in Fibrinolytic Activity of Atherosclerosic Quails
Zhang Bing, Lu Yong-cai. Study on the Effect and Mechanism of Tianjing Buxue Huayu OralLiquid in Fibrinolytic Activity of Atherosclerosic Quails[J]. Chinese Journal of Modern Applied Pharmacy, 1996, (6): 17-19.
Authors:Zhang Bing   Lu Yong-cai   
Abstract:The expement showed that Tianjing Buxue Huayu Oral Liquid (TJHYOL) restored tile fibtinolytic function of atherosclerosic quails by raising the activity of tissue plasminogen activator (t-PA), reducing the activity of plasminogen activator inhibitor (PAI) and regulating their activity ratio. The pharmacological mechanism is that TJHYOL reduces the amount oflipid deposition in arterial wall and blood viscosity. So it can protect the intravascular membranecells and maintain the function of fibrinolysis system. According to the experiment research, wethink TJHYOL is an ideal drug for treating and preventing atheroselerosis.
Keywords:: Chinese medicine  t-PA and PAI activity  Pathology  Viscosity  Atherosclerosis  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号